A Study of Opioid Prescribing Patterns in a Female Pelvic Surgery Practice

Overview

About this study

The objective for this study is to learn more about the opioid prescribing patterns in the Division of Urogynecology (Department of Obstetrics and Gynecology) at our institution for pelvic organ prolapse surgery (both abdominal and vaginal routes) and isolated synthetic midurethral sling placements.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Female patients:

Older than 18 years of age
Who are opioid naïve (defined as no history of opioid use within 30 days prior to their procedure
Undergoing reconstructive surgery for pelvic organ prolapse (vaginal, abdominal, or robotic), with or without concomitant anti-incontinence OR isolated synthetic midurethral sling placement
Who understand and have signed written informed consent for the study

Exclusion Criteria:

Patients that:

Have opioid use within 30 days prior to their procedure
Have complications requiring readmission or return to the operating room within 30 days of their index procedure

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator John Gebhart, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

John Gebhart, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials